Whitehawk Therapeutics, Inc.
WHWKUS売上高
$7M
百万USD
営業利益
$-114M
百万USD
純利益
$-21M
百万USD
ROE
-15.1%
最新FY
EPS
$-0.33
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-4M | - |
| FY2021 | Q2 | $15M | $-4M | - |
| FY2021 | Q3 | $0M | $-87M | - |
| FY2021 | FY | $1M | $-110M | - |
| FY2022 | Q1 | $2M | $-14M | - |
| FY2022 | Q2 | $3M | $-18M | $-0.87 |
| FY2022 | Q3 | $4M | $-14M | $-0.68 |
| FY2022 | FY | $15M | $-61M | $-2.69 |
| FY2023 | Q1 | $6M | $-15M | $-0.57 |
| FY2023 | Q2 | $6M | $-18M | $-0.67 |
| FY2023 | Q3 | $6M | $-16M | $-0.60 |
| FY2023 | FY | $24M | $-66M | $-2.44 |
| FY2024 | Q1 | $5M | $-18M | $-0.68 |
| FY2024 | Q2 | $6M | $-15M | $-0.54 |
| FY2024 | Q3 | $7M | $-13M | $-0.46 |
| FY2024 | FY | $26M | $-64M | $-2.36 |
| FY2025 | Q1 | $7M | $73M | $1.83 |
| FY2025 | Q2 | $0M | $-53M | $-0.76 |
| FY2025 | Q3 | $0M | $-18M | $-0.26 |
| FY2025 | FY | $7M | $-21M | $-0.33 |
| FY2026 | Q1 | $0M | $-22M | $-0.32 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $20M | $20M | $15M | $1M | $15M | $24M | $26M | $7M |
| 営業利益 | $-0M | $-21M | $-11M | $-24M | $-6M | $-111M | $-63M | $-72M | $-67M | $-114M |
| 純利益 | $-0M | $-21M | $-10M | $-23M | $-4M | $-110M | $-61M | $-66M | $-64M | $-21M |
| 総資産 | $0M | $21M | $64M | $40M | $45M | $158M | $184M | $132M | $70M | $151M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $-0M | $17M | $59M | $37M | $43M | $136M | $158M | $105M | $52M | $136M |
| 営業CF | $-0M | - | $-6M | $-24M | $-5M | $-22M | $-50M | $-60M | $-60M | $-97M |
| EPS | - | - | - | - | - | - | $-2.69 | $-2.44 | $-2.36 | $-0.33 |
| BPS | $-0.05 | $0.64 | $1.45 | $0.90 | $0.91 | $6.52 | $6.48 | $4.28 | $1.12 | $2.89 |
| ROE | 17.5% | -122.7% | -17.7% | -63.7% | -10.0% | -80.7% | -38.2% | -62.5% | -121.4% | -15.1% |